Series A - Earli

Series A - Earli

Investment Firm

Overview

Earli is a developer of cancer treatment devices designed to search for natural biomarkers.

Announced Date

Jan 12, 2021

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Khosla Ventures

Khosla Ventures

Khosla Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

12

Investor Name
Participant InvestorSands Capital Ventures
Participant InvestorJim Breyer
Participant InvestorMenlo Ventures
Participant InvestorAndreessen Horowitz
Participant InvestorKhosla Ventures

Round Details and Background

Earli raised $40000000 on 2021-01-12 in Series A

Earli is a developer of cancer treatment devices designed to search for natural biomarkers.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 22, 2018
Pre Seed Round - Earli
2-400.0K
Sep 17, 2018
Seed Round - Earli
11-19.5M
Jan 12, 2021
Series A - Earli
12-40.0M

Recent Activity

There is no recent news or activity for this profile.